Genomics Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031

The global genomics market is anticipated to grow at a considerable CAGR of 15.3% during the forecast period. The key factors that are contributing to the market growth are key players operating in the market are adopting various strategies such as acquisition, mergers, new product launches, and other are such factors that assist in market growth. For instance,

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/genomics-market

• In February 2022, Intellia Therapeutics, Inc., has acquired Rewrite Therapeutics, Inc., for the further expansion of Intellia's industry-leading genome editing toolbox with the addition of CRISPR/Cas9 and base editing technologies to make precisely targeted changes to DNA for new possibilities and the potential to target diseases.

• In April 2021, the Biden administration has invested $1.7 billion to improve the detection, monitoring, and mitigation of SARS-CoV-2 variants and also for building infrastructure for future genomic sequencing. This funding is made to expand the capacity for genomic sequencing, with additional future funding to follow that will reach $1 billion.

• In December 2020, AstraZeneca has acquired Alexion Pharmaceuticals, Inc., to build combined expertise in immunology and precision medicines to accelerate innovation and deliver enhanced value for shareholders, patients, and the rare disease communities.

• In June 2020, Merck and 10x Genomics, Inc., developed a new option for biological experiments with barcode technology to screen single cells using CRISPR libraries. Under this collaboration, companies are innovating two new technologies such as single cell transcriptomics and pooled CRISPR screening under the 10x Compatible Partnership Program.

Global Genomics Market Report Segment

By Deliverable

• Product
• Services

By Technology

• Sequencing
• PCR
• Nucleic Acid Extraction and Purification
• Microarray
• Other

By Application

• Drug Discovery and Development
• Diagnostics
• Agriculture and Animal Research
• Other

By End-User

• Hospitals & Clinics
• Academic and Research Centers
• Pharmaceutical & Biotechnology Companies
• Other

A full report of Genomics Market is available at: https://www.omrglobal.com/industry-reports/genomics-market

Genomics Market- Segment by Region

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• 23andMe
• Agilent Technologies, Inc.
• BEX CO.,LTD.
• Bio-Rad Laboratories, Inc.
• BGI
• Color Health, Inc.
• DEEP GENOMICS
• DNA and U
• Eppendorf SE
• Hoffmann-La Roche Ltd.
• General Electric Co.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.


Visit more report at

https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/

https://www.linkedin.com/pulse/aesthetic-threads-market-increasing-demand-growth-2031-vishwakarma-pyg5f

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.